Karyopharm Therapeutics Inc. · NASDAQ:KPTI

T. Rowe Price Investment Management, Inc. reported a 13.80% stake in Karyopharm Therapeutics Inc. (Schedule 13G/A)

Event Oct 31, 2025 · Filed Nov 7, 2025

T. Rowe Price Investment Management, Inc. reported a 13.80% stake in Karyopharm Therapeutics Inc., 2,304,242 shares, as a passive investor on Oct 31, 2025. Filed Nov 7, 2025 (Schedule 13G/A).

Stake
13.80%
Shares
2,304,242
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
T. Rowe Price Investment Management, Inc.13.80%2,304,242

Source

View original at SEC

Related